The overprovision of infectious disease medicine

This paper demonstrates a so far ignored negative externality imposed by the provision of life prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication.